ALK and neuroblastoma: Finally, we wondered whether PHOX2B protein decrease consequent to CQ and MMF treatment could result in down-regulation of Anaplastic Lymphoma Kinase (ALK) gene expression, whose transcription is PHOX2B-dependent and overexpression is considered pathogenic in neuroblastoma [7].